Announcements
BARDA Industry Day Lightning Talks
HHS, DoD, Spero co-sponsor novel oral antibiotic development to treat deadly infections
HHS, DoD, Spero co-sponsor novel oral antibiotic development to treat deadly infections
Statement by Rick Bright, PhD, Director of ASPR’s Biomedical Advanced Research and Development Authority on the recent FDA approval of TPOXX® as a treatment for smallpox
“The Food and Drug Administration’s (FDA) approval of TPOXX® (tecovirimat) as a treatment for smallpox marks a milestone for biosecurity and a triumph against one of the most deadly diseases in history. TPOXX®, produced by SIGA Technologies, is the first – and only—FDA-approved smallpox antiviral treatment.”
